Ellen de Kort

169 General discussion 9 72. Dempsey EM, Barrington KJ. Diagnostic criteria and therapeutic interventions for the hypotensive very low birth weight infant. J Perinatol 2006;26:677-681. 73. DempseyEM,AlHazzani F, BarringtonKJ. Permissivehypotension in theextremelylowbirthweight infant with signs of good perfusion. Arch Dis Child Fetal Neonatal Ed 2009;94:F241-F244. 74. Lerman J, Heard C, Steward DJ. Neonatal tracheal intubation: an imbroglio unresolved. Pediatr Anesth 2010;20:585-590. 75. Thewissen L, Caicedo A, Dereymaeker A, Van Huffel S, Naulaers G, Allegaert K, Smits A. Cerebral autoregulation and activity after propofol for endotracheal intubation in preterm neonates. Pediatr Res. 2018;84(5):719-725. 76. Vanderhaegen J, Naulaers G, Van Huffel S, Vanhole C, Allegaert K. Cerebral and systemic hemodynamic effects of intravenous bolus administration of propofol in neonates. Neonatology 2010;98:57-63. 77. Vedrenne-Cloquet M, Breinig S, Dechartres A, Jung C, Renolleau S, Marchand-Martin L et al. Cerebral oxygenation during neonatal intubation – ancillary study of the Prettineo-study. Front Pediatr 2019;7:1-8. 78. Hsieh EM, Hornik CP, Clark RH, Laughon MM, Benjamin DK Jr, Smith PB, et al. Mediation use in the neonatal intensive care unit. Am J Perinatol 2014;31:811-821. 79. Flint RB, van Beek F, Andriessen P, Zimmermann LJ, Liem KD, Reiss IKM, et al. Large differences in neonatal drug use between NICUs are common practice: time for consensus? Br J Clin Pharmacol 2018;84:1313-1323. 80. De Kort EHM, Reiss IKM, Simons SHP. Sedation of newborn infants for the INSURE procedure, are we sure? BioMed Res Int 2013;2013:892974. doi. 10.1155/2013/892974. 81. Kribs A, Roll C, Göpel W, Wieg C, Groneck P, Laux R, Teig N, Hoehn T, Böhm W, Welzing L, VochemM, Hoppenz M, Bührer C, Mehler K, Stützer H, Franklin J, Stöhr A, Herting E, Roth B; for the NINSAPP Trial Investigators. Nonintubated surfactant application vs conventional therapy in extremely preterm infants. A randomized controlled trial. JAMA Pediatr 2015;169:723-730. 82. GöpelW, KribsA, ZieglerA, Laux R, HoehnT,Wieg C et al.; German Neonatal Network. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomized, controlled trial. Lancet 2011;378:1627-1634. 83. Dargaville P, Aiyappan A, De Paoli AG, Kuschel CA, Kamlin COF, Carlin JB, Davis PG. Minimally- invasive surfactant therapy in preterm infants on continuous positive airway pressure. Arch Dis Child Fetal Neonatal Ed 2013;98:F122-126. 84. Kurepa D, Perveen S, Lipener Y, Kakkilaya V. The use of less invasive surfactant administration (LISA) in the united states with review of the literature. J Perinatol 2019;39:426-432. 85. Klotz D, Porcaro U, Fleck T, Fuchs H. European perspective on less invasive surfactant administration – a survey. Eur J Pediatr 2017:176:147-154. 86. Jeffreys E, Hunt K, Dassios T, Greenough A. UK survey of less invasive surfactant administration. Arch Dis Child Fetal Neonatal Ed 2019;0:F1. 87. Heiring C, Jonsson B, Andersson S, Björklund L. Survey shows large differences between the Nordic countries in the use of less invasive surfactant administration. Acta Paediatr 2016;106:382- 386. 88. Bhayat S, Kaur A, Premadeva I, Reynolds P, Gowda H. Survey of less invasive surfactant administration in England, slow adoption and variable practice. Acta Paediatr 2019;00:1-6. 89. Janssen LCE, Van der Spil J, Van Kaam AH, Dieleman JP, Andriessen P, Onland W, Niemarkt HJ. Minimally invasive surfactant therapy fialure: risk factors and outcome. Arch Dis Child Fetal Neonatal Ed 2019;104:F636-F642.